DSH Litigation and 340B Program Update: What Participating Hospitals Need to Know and What They Should Be Doing
|
|
- Ilene Young
- 8 years ago
- Views:
Transcription
1 DSH Litigation and 340B Program Update: What Participating Hospitals Need to Know and What They Should Be Doing Presented by: Joe Metro, Partner Sal Rotella, Partner
2 Agenda Disproportionate Share Hospital (DSH) Payments DSH Basics Allina (Part C/Part A Issue) Catholic Health Initiatives (Medi-Medi Issue) Revised Notices of Program Reimbursement (SSI Issue) 340B Drug Pricing Program Key issues in 340B program rulemaking (if any) Evaluating contract pharmacy arrangements Managing internal and external 340B compliance audits 2
3 DSH Litigation 3
4 DSH Basics What is DSH? Supplemental Medicare payments to compensate hospitals for higher operating costs incurred treating large share of low-income patients DSH funds preserve access to care for Medicare and low-income populations by financially assisting hospitals they use DSH Patient Percent (DPP) determines DSH eligibility and amount of DSH payment 4
5 DSH Basics: How is DSH calculated? DPP = Medicare/SSI Fraction + Medicaid Fraction Numerator Medicare/SSI Fraction Patient days for patients entitled to benefits under Part A and entitled to SSI benefits Medicaid Fraction Patient days for patients eligible for [Medicaid] but not entitled to benefits under Part A Denominator Patient days for patients entitled to benefits under Part A Total number of patient days DSH appeals challenge treatment of various types of patient days in calculating DPP Methodology for calculating DSH payments changing pursuant to 2014 IPPS Final Rule 5
6 Allina Health Services v. Sebelius Part C/Part A Issue Pursuant to 2004 Final Rule, HHS treats inpatient days of Part C beneficiaries as days for which those patients were entitled to Part A benefits for purposes of calculating DPP Rationale is that being entitled to Part A is prerequisite to being eligible to enroll in Part C plan HHS approach generally lowers DPP 6
7 Allina Health Services v. Sebelius (cont.) Allina (D.C. Court of Appeals decision April 1, 2014) Involved Part C/Part A Issue challenge to 2007 cost year DPP Affirmed district court s pro-hospital ruling that 2004 Final Rule dictating treatment of Part C days was invalid BUT, reversed trial court s pro-hospital ruling that HHS must re-calculate 2007 cost year at issue and this time treat Part C patients as not entitled to Part A benefits Upshot HHS can reach same decision based on administrative adjudication rather than regulation Unlike regulation, administrative decision generally does have retroactive effect 7
8 Catholic Health Initiatives v. Sebelius Medi-Medi Issue Pursuant to 2004 Final Rule, HHS treats inpatient days for which dual eligible beneficiaries have exhausted their Medicare Part A benefits as days for which those patients are nonetheless entitled to Part A benefits for purposes of calculating the DPP Rationale is that dual eligibles are still entitled to Part A after exhausting benefits, even though Part A isn t paying for stay HHS approach generally lowers DPP 8
9 Catholic Health Initiatives v. Sebelius (cont.) Catholic Health (D.C. Court of Appeals decision June 11, 2013; plaintiff chose not to seek further review by Supreme Court) Involved challenge to 1997 cost year DPP Reversed district court s ruling in favor of hospital on Medi-Medi Issue Found that entitled to Medicare Part A is ambiguous and could encompass dual eligible inpatients who have exhausted their Part A benefits Legal test was therefore only if government s construction of statute was permissible; D.C. Circuit found that it was Retroactivity Hospital had successfully argued to district court that government could not retroactively apply Medi-Medi Issue approach from 2004 Final Rule to 1997 cost year D.C. Circuit found that government could apply Medi-Medi Issue approach to earlier (1997) cost year, because approach was first reached in adjudication in 2000, not Final Rule in
10 Revised NPRs SSI Issue Hospitals argued that in calculating DPP, CMS was using improper data matching process and undercounting patients receiving SSI benefits In 2008, federal district court found in hospitals favor in Baystate Medical Center v. Leavitt Ruling 1498-R Instead of appealing Baystate, CMS issued Ruling 1498-R in April 2010 Ruling provided that CMS would remand all properly appending SSI Issue appeals (i.e., appeals challenging data matching process) Remand meant that appeal was concluded and CMS would issue revised NPR using improved data match process 10
11 Revised NPRs (cont.) Status of Revised NPRs and Payments CMS has issued recalculated SSI percentages using updated data matching process for Unclear why MACs have not yet issued revised NPRs and payments for all of these years CMS obligated to likewise recalculate SSI percentages, and issue revised NPRs and payments for 2005 and prior CMS said as recently as early 2014 that it was only waiting on resolution of Catholic Health case, which is now resolved Speculation that CMS was also waiting on decision in Allina, but that has now issued as well Media expressing interest in continuing delay 11
12 340B Program Update 12
13 340B Program Proposed Rule Current status: Proposed rule submitted to OMB for Regulatory Review on 4/9/ day review window plus 30-day extension authorized Summer vacation reading? PhRMA v. HHS (D.D.C. May 23, 2014) The best laid plans Holds HHS final rule implementing orphan drug rule invalid HRSA 340B rulemaking authority only extends to price calculation, dispute resolution, and CMPs Potential for delay of mega-rule, continued informal guidance, and resolution through adjudication Note also CMS Medicaid rebate rulemaking is pending AMP/BP methodologies can affect 340B discounted price calculation Medicaid managed care duplicate discount mechanisms? 13
14 Proposed Rule/Future Guidance: Key Issues to Watch Entity qualification and registration GPO exclusion Imposition of duties as part of registration process Covered outpatient drugs ER settings Orphan drug exclusion Patient definition and identification Replenishment models Duplicate discounts and Medicaid managed care Corrective action Mechanisms Duty to report Audit and dispute procedures 14
15 Contract Pharmacy Arrangements February 2014 OIG Report finds contract pharmacy arrangements create complications in preventing diversion and duplicate discounts, and covered entities oversight and auditing of contract pharmacies was inconsistent Key Issues in contract pharmacy relationships Mechanism for 340B-eligible patient dispensing Billing Uninsured patients Third-party payors Medicaid carve-in vs. carve-out Compensation Ordering and inventory maintenance Reporting and auditing 15
16 HRSA FY B Program Audit Summary 51 CEs / 412 subgrantees / 860 contract pharmacy locations Common areas of noncompliance for hospital covered entities Violation of GPO prohibition (42 percent of hospitals) Diversion (36 percent) Billing contrary to exclusion file (24 percent) Database errors (21 percent) Best practices SOPs Routine self-auditing and corrective action Strong state relationships and coordination Verification of database 16
17 Managing 340B Audits HRSA, manufacturer, and entity audit activity likely to continue in light of policy oversight and rulemaking Policies and procedures Understand method and data by which you will prove compliance, including under replenishment models GPO prohibition/orphan drug exclusion Initial purchases Ordering and dispensing data reconciliation Patient identification Prescriber Location Corrective Action True-up of inventory vs. refund Notice to manufacturer/hrsa Medicaid 17
18 Questions? 18
19 Contact Information Joseph W. Metro Partner, Washington, D.C Salvatore G. Rotella, Jr. Partner, Philadelphia
340B Drug Pricing Program. A Survey of the Program s Past, Present, and Future
340B Drug Pricing Program A Survey of the Program s Past, Present, and Future Presented by: Daniel Soldato Wyatt, Tarrant & Combs LLP dsoldato@wyattfirm.com (859) 288-7631 Disclaimer The views expressed
More information340B Drug Pricing Program: Recent Developments and Compliance Update
340B Drug Pricing Program: Recent Developments and Compliance Update Elizabeth S. Elson, Esq. Anil Shankar, Esq. November 19, 2015 Attorney Advertising Prior results do not guarantee a similar outcome
More information340B program presents opportunities and challenges
NOVEMBER 2009 healthcare financial management MEDICARE/MEDICAID Christopher L. Keough Stephanie A. Webster 340B program presents opportunities and challenges AT A GLANCE > The 340B program provides an
More informationCPAs and ADVISORS. experience access // 340B QUALIFICATIONS, BENEFITS AND CURRENT FOCUS
CPAs and ADVISORS experience access // 340B QUALIFICATIONS, BENEFITS AND CURRENT FOCUS BRIAN M. BELL BRAD K. BROTHERTON DIRECTOR PARTNER MATERIALS COVERED TODAY 340B Program Evolution, Purpose & Benefits
More informationA fter much-anticipation, the Health Resources and
BNA s Health Care Policy Report Reproduced with permission from BNA s Health Care Policy Report, 23 HCPR 1420, 09/21/2015. Copyright 2015 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com
More information340B Drug Discount Program Improving Compliance to Protect Savings and Be Audit Ready. Suzanne Herzog Founding Director Rx X Consulting
340B Drug Discount Program Improving Compliance to Protect Savings and Be Audit Ready Suzanne Herzog Founding Director Rx X Consulting What is 340B? 340B Overview A drug discount program that allows covered
More informationFinally... maybe? The Long Awaited 340B Mega Guidance. Georgia Healthcare Financial Management Association. October 2015
Finally... maybe? The Long Awaited 340B Mega Guidance Georgia Healthcare Financial Management Association October 2015 Disclaimer This webinar assumes the participant is familiar with the basic operations
More informationOctober 9, 2015. RIN 0906-AB08 340B Drug Pricing Program Omnibus Guidance. Dear Director Pedley:
October 9, 2015 Krista Pedley Director, Office of Pharmacy Affairs Health Resources and Services Administration 5600 Fishers Lane Mail Stop 08W05A Rockville, Maryland 20857 Re: RIN 0906-AB08 340B Drug
More informationEligibility of Rural Hospitals for the 340B Drug Discount Program
Public Hospital Pharmacy Coalition www.phpcrx.org (A Coalition of the National Association of Public Hospitals and Health Systems) Eligibility of Rural Hospitals for the 340B Drug Discount Program Prepared
More informationFederal 340B Drug Pricing Program
2015 CliftonLarsonAllen LLP Federal 340B Drug Pricing Program March 6, 2015 Continuous learning in action Learning Objectives Explain the intent of the Federal 340B Drug Pricing Program List the eligibility
More informationXXXXXXXFUNDAMENTALS An Essential Guide for Health System Executive Management
340B XXXXXXXFUNDAMENTALS An Essential Guide for Health System Executive Management 800.473.3516 www.wellpartner.com Table of Contents 340B Fundamentals for Health System Executive Management...1 What
More informationThe 340B Drug Discount Program Overview, Compliance Issues and Interplay with Medicare and Medicaid
The Drug Discount Program Overview, Compliance Issues and Interplay with Medicare and Medicaid Barbara Straub Williams Powers Pyles Sutter & Verville PC American Health Lawyers Association 2014 Institute
More informationKeep Your Savings: 340B Audits and Ensuring Compliance
Keep Your Savings: 340B Audits and Ensuring Compliance Disclosure This presentation reflects experience with the topics at hand and does not constitute legal advice, and does not reflect interpretation
More informationLegal Alert. Long-Awaited 340B Program Guidance Now Available for Comments: What Stakeholders Need to Know. Authors
September 10, 2015 1 Legal Alert Authors Stephanie Trunk Partner stephanie.trunk@arentfox.com Erin E. Atkins Associate erin.atkins@arentfox.com Long-Awaited 340B Program Guidance Now Available for Comments:
More information340B Omnibus Guidance Would Significantly Narrow the Pool of Eligible Patients
White Paper August 31, 2015 340B Omnibus Guidance Would Significantly Narrow the Pool of Eligible Patients By Kristi V. Kung This client alert also was published as a bylined article on Law360 on September
More information340B Drug Pricing Program: Overview and Recent Developments
340B Drug Pricing Program: Overview and Recent Developments November 12, 2015 Kirstin B. Ives Partner and Chair of Healthcare Litigation Group Williams Montgomery & John Ltd. 233 S. Wacker Drive, Suite
More information340B Drug Pricing Program
340B Drug Pricing Program Chad E. Gay Director of Contract Compliance Agenda Discuss the 340B drug pricing program How the program is defined Who is eligible Enrollment Dates to be aware of Source Documentation
More information340B DRUG DISCOUNT PROGRAM OMNIBUS GUIDANCE. Presented by the American Bar Association Health Law Section and Center for Professional Development
340B DRUG DISCOUNT PROGRAM OMNIBUS GUIDANCE Presented by the American Bar Association Health Law Section and Center for Professional Development American Bar Association Center for Professional Development
More informationThe Pharmacy 340B Program- Compliance & Internal Audit Strategies. for Covered Entities. Matthew D. Vogelien Huron Healthcare
The Pharmacy 340B Program- Compliance & Internal Audit Strategies Matthew D. Vogelien Huron Healthcare for Covered Entities 340B Drug Discount Program (340B Program) Discussion Outline Topics for Discussion:
More information340B Mega Guidance: Implications for Essential Hospitals Sarah Mutinsky and Barbara Eyman Washington Counsel, America s Essential Hospitals Eyman
340B Mega Guidance: Implications for Essential Hospitals Sarah Mutinsky and Barbara Eyman Washington Counsel, America s Essential Hospitals Eyman Associates September 10, 2015 TODAY S AGENDA Background
More information2015-340B & Prime Vendor Program Update
2015-340B & Prime Vendor Program Update Christopher A. Hatwig, R.Ph., MS, FASHP President, Apexus 340B Sales by Entity Types Percentage of Total Apexus Participant Sales 90.00% 80.00% 70.00% 60.00% 50.00%
More informationMega Guidance Is Here!
Mega Guidance Is Here! David Pointer has no actual or potential conflict of interest in relation to this presentation. 1 Introduction Where are we today? Brief Overview of HRSA Audit Findings Where are
More informationMega Guidance Is Here!
Mega Guidance Is Here! David Pointer has no actual or potential conflict of interest in relation to this presentation. Introduction Where are we today? Brief Overview of HRSA Audit Findings Where are we
More informationHRSA Publishes 340B Drug Pricing Program Omnibus Guidance Notice: Significant Policy Ramifications Should Trigger Public Comment
Alert Life Sciences Health Industry If you have questions or would like additional information on the material covered in this Alert, please contact one of the attorneys listed below: Joseph W. Metro Partner,
More informationThe 340B Drug Pricing Program. Ariel Winter and Daniel Zabinski November 6, 2014
The 340B Drug Pricing Program Ariel Winter and Daniel Zabinski November 6, 2014 Outline Background on 340B program Program has grown substantially 340B statute does not define key terms, allows many providers
More informationThe 340B Program: New Developments and New Opportunities for CAHs and Others. Todd Nova Hall Render
The 340B Program: New Developments and New Opportunities for CAHs and Others Todd Nova Hall Render Wisconsin Office of Rural Health Hospital Finance Workshop August 30, 2011 What We Will Cover 2 340B Program
More informationSec. 340B PUBLIC HEALTH SERVICE ACT
Sec. 340B PUBLIC HEALTH SERVICE ACT LIMITATION ON PRICES OF DRUGS PURCHASED BY COVERED ENTITIES (a) REQUIREMENTS FOR AGREEMENT WITH SECRETARY. (1) IN GENERAL. The Secretary shall enter into an agreement
More information340B Drug Discount Program Identifying risks and internal audit focus areas
340B Drug Discount Program Identifying risks and internal audit focus areas Introduction The 340B Drug Discount Program is administered by the Health Resources and Services Administration (HRSA) Office
More information340B Program New Developments and Increasing Scrutiny
340B Program New Developments and Increasing Scrutiny Todd Nova Hall Render tnova@hallrender.com Wisconsin Office of Rural Health Hospital Finance Workshop August 24, 2012 What We Will Cover 2 340B Program
More information340B Drug Discount Program Overview and Emerging Issues
340B Drug Discount Program Overview and Emerging Issues I. APPLICABLE STATUTE AND OTHER LEGAL AUTHORITIES Section 340B of the Public Health Service Act (42 U.S.C. 256b) requires pharmaceutical manufacturers,
More informationSpeakers. Recent Developments in 340B Drug Pricing Program Compliance and Enforcement. Elizabeth S. Elson, Esq. Anil Shankar, Esq.
1 Recent Developments in 340B Drug Pricing Program Compliance and Enforcement Elizabeth S. Elson, Esq. Anil Shankar, Esq. October 18, 2012 2 Speakers Elizabeth Elson Of Counsel Foley & Lardner LLP Los
More information340B: ARE WE MONITORING COMPLIANCE EFFECTIVELY AND EFFICIENTLY
CPAs & ADVISORS experience clarity // 340B: ARE WE MONITORING COMPLIANCE EFFECTIVELY AND EFFICIENTLY September 17, 2014 Michael Earls, CPA, Senior Manager September 17, 2014 OVERVIEW OF TODAY S PRESENTATION
More information340B Policy Landscape
340B Policy Landscape Providence 2015 340B Summit Presented by Steve Brennan, Director, Public Policy Providence Health & Services Sept. 28, 2015 1 Today s topics Backdrop of debate over 340B program Legislative
More informationHHS Releases Long-Awaited 340B Proposed Guidance
AUGUST 31, 2015 HHS Releases Long-Awaited 340B Proposed Guidance David Ivill, Emily Cook and Joseph Parise On August 27, 2015, the U.S. Department of Health and Human Services (HHS) released the long-awaited
More informationkaiser medicaid and the uninsured commission on September 2011
P O L I C Y B R I E F kaiser commission on medicaid and the uninsured September 2011 Explaining Douglas v. Independent Living Center: Questions about the Upcoming United States Supreme Court Case Regarding
More informationStructuring 340B Contract Pharmacy Arrangements: Meeting Legal and Regulatory Requirements
Presenting a live 90-minute webinar with interactive Q&A Structuring 340B Contract Pharmacy Arrangements: Meeting Legal and Regulatory Requirements THURSDAY, JUNE 4, 2015 1pm Eastern 12pm Central 11am
More informationNAMD WORKING PAPER SERIES. Medicaid and the 340B Program: Alignment and Modernization Opportunities
NAMD WORKING PAPER SERIES Medicaid and the 340B Program: Alignment and Modernization Opportunities May 2015 444 North Capitol Street, Suite 524 Washington, DC 20001 Phone: 202.403.8620 www.medicaiddirectors.org
More information340B Drug Pricing Program January 15, 2015
340B Drug Pricing Program January 15, 2015 340B Basics - Gary Merchant. MBA, BSPharm 340B Audit - Robert Theriault, MBA, BSPharm Declarations Neither Gary Merchant nor Robert Theriault have no actual or
More informationASHP Regulatory Alert
Proposed Guidance: 340B Drug Discount Program Introduction On Friday, August 28, 2015, the Health Resources and Services Administration (HRSA) published the long awaited proposed omnibus guidance for the
More informationAffordable Care Act Reviews
Page 66 Appendix A Affordable Care Act Reviews The Office of Inspector General (OIG) is focused on promoting the economy, efficiency, and effectiveness of Affordable Care Act 1 programs across the Department
More informationOIG Responses to Additional Questions from Chairman Pitts Regarding the 340B Program May 4, 2015
OIG Responses to Additional Questions from Chairman Pitts Regarding the 340B Program May 4, 2015 1. HRSA had been preparing a regulation to address the definition of a patient and hospital eligibility,
More informationO n Aug. 28, the Department of Health and Human
BNA s Health Law Reporter Reproduced with permission from BNA s Health Law Reporter, 24 HLR 1202, 9/17/15. Copyright 2015 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com HRSA
More information340B Compliance: I sure wish I d known that!
340B Compliance: I sure wish I d known that! Aaron K. Lott Pharm. D. Executive Director of Pharmacy Services June 2015 Disclosures The presenter has no significant financial or commercial interests to
More information340B PROGRAM. Scrutiny & Uncertainty Increase the Need for Compliance
340B PROGRAM Scrutiny & Uncertainty Increase the Need for Compliance Uncertainty will always be part of the taking charge process. Harold S. Geneen For many years, drug manufacturers and Covered Entities
More informationFast Track to 340B FEATURE: ROBERT F. GRICIUS AND DOUGLAS WONG
HFM MAGAZINE:JANUARY 2016 Fast Track to 340B FEATURE: ROBERT F. GRICIUS AND DOUGLAS WONG MANY HOSPITALS AND HEALTH SYSTEMS HAVE A PROFOUND NEW OPPORTUNITY TO OBTAIN SAVINGS ON OUTPATIENT PHARMACEUTICALS
More information340B University Page 1 Split-Billing Software Considerations Checklist
340B University Page 1 Purpose: The purpose of this tool is to provide a decision checklist for entities to evaluate split-billing software. The tool presents considerations for an entity when selecting,
More informationSUMMARY OF HRSA PROPOSED OMNIBUS GUIDANCE ON THE 340B DRUG DISCOUNT PROGRAM
L A W O F F I C E S HYMAN, PHELPS & MCNAMARA, P.C. 7 0 0 T H I R T E E N T H S T R E E T, N. W. S U I T E 1 2 0 0 W A S H I N G T O N, D. C. 2 0 0 0 5-5 9 2 9 ( 2 0 2 ) 7 3 7-5 6 0 0 F A C S I M I L E
More informationHRSA Issues Proposed Omnibus 340B Guidance
HRSA Issues Proposed Omnibus 340B Guidance September 2015 1 HRSA Issues Proposed Omnibus 340B Guidance John Gould, Jeffrey L. Handwerker, Rosemary Maxwell, Matthew T. Fornataro, Kristin M. Hicks, Rahul
More informationDate: September 3, 2014
Date: September 3, 2014 Subject: Background on Sections 401 and 403 of the Indian Health Care Improvement Act: Disregarding Certain Payments in Determining Appropriations and Reporting Requirements Note:
More informationMajor DSH Changes Under PPACA
Affordable Care Act Changes to Medicare DSH: Now That CMS s Proposal Is Here, What Does it Say? Dennis Barry Mark Polston Gregory Etzel 1 Major DSH Changes Under PPACA Section 3133 of the Patient Protection
More informationToday s Agenda. Statement of Conflicts of Interest 7/9/2015
Geri Brennan Assistant Director, Health Care United States Government Accountability Office Statement of Conflicts of Interest Geri Brennan has no actual or potential conflict of interest in relation to
More informationDisclosure. Overview. Safety Net Hospitals for Pharmaceutical Access
340B: Issues and Opportunities in Pharmacy Automation Safety Net Hospitals for Pharmaceutical Access Executive Director, SNHPA Editor in Chief, Drug Discount Monitor American Society for Automation in
More information340B Integrity Audit: Is Your Hospital Ready for a HRSA Audit? February 4, 2013
340B Integrity Audit: Is Your Hospital Ready for a HRSA Audit? February 4, 2013 1 Agenda 340B Program Overview Why HRSA Audits? What will HRSA Audits Cover? Verification of Eligibility: Covered Entity,
More information340B Drug Discount Program 2013 March 15, 2013 1 Agenda 340B Program Overview Covered Entities Covered Drugs Covered Patients Why HRSA Audits How to Prepare for HRSA Audit Questions/Answers 2 340 DRUG
More informationSTATEMENT OF DIANA ESPINOSA DEPUTY ADMINISTRATOR, HEALTH RESOURCES AND SERVICES ADMINISTRATION BEFORE THE
STATEMENT OF DIANA ESPINOSA DEPUTY ADMINISTRATOR, HEALTH RESOURCES AND SERVICES ADMINISTRATION BEFORE THE U.S. HOUSE ENERGY AND COMMERCE COMMITTEE SUBCOMMITEE ON HEALTH WASHINGTON, D.C. MARCH 5, 2015 Good
More informationSTATES COLLECTION OF REBATES FOR DRUGS PAID THROUGH MEDICAID MANAGED CARE ORGANIZATIONS
Department of Health and Human Services OFFICE OF INSPECTOR GENERAL STATES COLLECTION OF REBATES FOR DRUGS PAID THROUGH MEDICAID MANAGED CARE ORGANIZATIONS Daniel R. Levinson Inspector General September
More informationHRSA Issues 340B Program Omnibus Guidance
3 September 2015 Practice Groups: Healthcare FDA HRSA Issues 340B Program Omnibus Guidance By Gina L. Bertolini, Richard P. Church, Leah D'Aurora Richardson On August 28, 2015, the Health Resources and
More informationThe 3 Keys to Success in Your 340B Program. Rob Nahoopii, PharmD, MS, BCPS CEO Turnkey Pharmacy Solutions A 340B Management Company
The 3 Keys to Success in Your 340B Program Rob Nahoopii, PharmD, MS, BCPS CEO Turnkey Pharmacy Solutions A 340B Management Company Objectives Provide a description and overview of the 340B program Discuss
More informationNAPH Summary of Proposed Medicare DSH Regulations
NAPH Summary of Proposed Medicare DSH Regulations On Friday, April 26, the Centers for Medicare & Medicaid Services (CMS) released a proposed rule implementing the Medicare disproportionate share hospital
More information7/16/2010. 14 th Annual 340B Coalition Conference July 19, 2010 Washington, DC. Safety Net Hospitals for Pharmaceutical Access
Safety Net Hospitals for Pharmaceutical Access The Story From Washington, D.C. Ted Slafsky Executive Director, SNHPA Editor in Chief, Drug Discount Monitor (202)552-58605860 ted.slafsky@snhpa.org 14 th
More informationThe 340B Program: Today and Beyond
FL Regional Education Session - Tampa The 340B Program: Today and Beyond May 19, 2015 2:15-3:15 PM ET 2015 Safety Net Hospitals for Pharmaceutical Access 1 Disclaimer This presentation is not to be construed
More informationMEDICARE PART B DRUGS. Action Needed to Reduce Financial Incentives to Prescribe 340B Drugs at Participating Hospitals
United States Government Accountability Office Report to Congressional Requesters June 2015 MEDICARE PART B DRUGS Action Needed to Reduce Financial Incentives to Prescribe 340B Drugs at Participating Hospitals
More informationOverview of the 340B Drug Pricing Program
M a y 2 0 1 5 Report to the Congress Overview of the 340B Drug Pricing Program M a y 2 0 1 5 Report to the Congress Overview of the 340B Drug Pricing Program 425 I Street, NW Suite 701 Washington, DC 20001
More informationMEDICARE DSH CASES -- CMS ISSUES IMPORTANT RULING
MEDICARE DSH CASES -- CMS ISSUES IMPORTANT RULING May 13, 2010 On April 28, 2010, the Centers for Medicare & Medicaid Services (CMS) issued CMS Ruling 1498-R (the Ruling), a major ruling affecting thousands
More informationMedicaid and 340B. Presentation to: GHA 340B Day Presented by: Linda Wiant, Pharm.D. Pharmacy Director. Date: 10-23-14 0
Medicaid and 340B Presentation to: GHA 340B Day Presented by: Linda Wiant, Pharm.D. Pharmacy Director Date: 10-23-14 0 Mission The Georgia Department of Community Health We will provide Georgians with
More information10/1/2013. Objectives. 340B Drug Pricing Program; Transitioning from Access to Integrity. 340B Stats, Arkansas. 340B Participating Entities, AR
Objectives Drug Pricing Program; Transitioning from Access to Integrity Arkansas Association of Health-system Pharmacists 47 th Annual Fall Seminar October 3 & 4, 2013 Chris Hatwig RPh, MS, FASHP President,
More information(RIN) 0906-AB08; 340-B
October, 2015 Ms. Krista Pedley Director, Office of Pharmacy Affairs (OPA) Health Resources and Services Administration (HRSA) 5600 Fishers Lane, Mail Stop 08W05A Rockville, Maryland 20857 Re: Regulatory
More information-1058- BEFORE THE DEPARTMENT OF PUBLIC HEALTH AND HUMAN SERVICES OF THE STATE OF MONTANA ) ) ) ) )
-1058- BEFORE THE DEPARTMENT OF PUBLIC HEALTH AND HUMAN SERVICES OF THE STATE OF MONTANA In the matter of the amendment of ARM 37.85.104 and 37.85.105 pertaining to the revision of fee schedules for Medicaid
More informationNACHC ANALYSIS: Establishing and Collecting Fees for Health Center Services. July, 2009
NACHC ANALYSIS: Establishing and Collecting Fees for Health Center Services July, 2009 Prepared for NACHC by: Michael Glomb Feldesman, Tucker, Leifer, Fidell 2001 L Street, N.W. (202)466-8960 mglomb@feldesmantucker.com
More informationSPECIAL TOPICS IN GUARDIANSHIP COMPROMISING CLAIMS FOR MINORS AND INCAPACITATED ADULTS. November 8, 2013
SPECIAL TOPICS IN GUARDIANSHIP COMPROMISING CLAIMS FOR MINORS AND INCAPACITATED ADULTS November 8, 2013 Stephanie F. Brown McMickle, Kurey & Branch 200 South Main Street Alpharetta, GA 30009 (678) 824-7800
More informationSECTION 18 1 FRAUD, WASTE AND ABUSE
SECTION 18 1 FRAUD, WASTE AND ABUSE Annual FW&A Training Required for Providers and Office Staff 1 Examples of Fraud, Waste and Abuse 2 Fraud, Waste and Abuse Program Policy 3 Suspected Non-Compliance
More informationCOMMENTARY. 2015 HHS OIG Work Plan Focuses on Payment Accuracy, Privacy Concerns, and Insurance Marketplaces. Reviews Related to Hospitals
November 2014 COMMENTARY 2015 HHS OIG Work Plan Focuses on Payment Accuracy, Privacy Concerns, and Insurance Marketplaces On October 31, 2014, the Department of Health and Human Services ( HHS ), Office
More informationHFMA Regulatory Conference
HFMA Regulatory Conference October 29, 2015 DoubleTree by Hilton Minneapolis-Park Place 1500 Park Place Blvd Minneapolis, MN 55416 www.doubletreeminneapolis.com 951-542-8600 Registration Information Cost
More informationEnsuring Integrity in use of 340B pricing: Responsibility, Compliance, Accountability
Ensuring Integrity in use of 340B pricing: Responsibility, Compliance, Accountability Fern Paul-Aviles, PharmD, MS, BCPS Director, 340B and Ambulatory Regulatory Program Compliance Carolinas Healthcare
More information4/3/2015 WHAT IS 340B? DISCLOSURE. No conflicts of interest to disclose
WHAT IS 340B? S C O T T M I L N E R P H AR M D, M B A DISCLOSURE No conflicts of interest to disclose 1 OBJECTIVES At the end of this presentation we should be able to: Describe the origin of the 340b
More informationMinimum Performance and Service Criteria for Medicare Part D
Minimum Performance and Service Criteria for Medicare Part D 1. Terms and Conditions. In addition to the other terms and conditions of the Pharmacy Participation Agreement ( Agreement ), the following
More informationGROWTH OF THE 340B PROGRAM: PAST TRENDS, FUTURE PROJECTIONS
: PAST TRENDS, FUTURE PROJECTIONS Healthcare WHITE PAPER NOVEMBER 2014 Prepared By: Aaron Vandervelde avandervelde@thinkbrg.com 202.480.2661 Copyright 2014 by Berkeley Research Group, LLC. Except as may
More informationSECTION 12 - REIMBURSEMENT METHODOLOGY
SECTION 12 - REIMBURSEMENT METHODOLOGY 12.1 THE BASIS FOR ESTABLISHING A RATE OF PAYMENT...2 12.2 DETERMINING A FEE...2 12.2.A LONG-TERM CARE DISPENSING FEE REQUIREMENTS...3 12.3 MEDICARE/MEDICAID REIMBURSEMENT
More informationIs your organization 340B equipped? Understanding Contract Pharmacy arrangements
Is your organization 340B equipped? Understanding Contract Pharmacy arrangements In today s era of healthcare reform that emphasizes enhanced accessibility and cost reductions, the 340B program remains
More informationWhen Public Payment Declines, Does Cost-Shifting Occur? Hospital and Physician Responses. November 13, 2002 Washington, DC
When Public Payment Declines, Does Cost-Shifting Occur? Hospital and Physician Responses November 13, 2002 Washington, DC These materials were commissioned by the Robert Wood Johnson Foundation for use
More informationEXECUTIVE SUMMARY OBJECTIVE The objective of our review was to confirm that disproportionate share hospital (DSH) payments to St. Vincent Charity Hospital and St. Luke s Medical Center (collectively, the
More information42 USC 256b. NB: This unofficial compilation of the U.S. Code is current as of Jan. 4, 2012 (see http://www.law.cornell.edu/uscode/uscprint.html).
TITLE 42 - THE PUBLIC HEALTH AND WELFARE CHAPTER 6A - PUBLIC HEALTH SERVICE SUBCHAPTER II - GENERAL POWERS AND DUTIES Part D - Primary Health Care subpart vii - drug pricing agreements 256b. Limitation
More informationC. Covered 340B drugs, as found in section 1927 (k)(2) of the Social Security Act, include the following outpatient drugs:
Title 23: Medicaid Part 200: General Provider Information Part 200 Chapter 4: Provider Enrollment Rule 4.10: 340B Providers A. The Division of Medicaid defines a 340B provider as a nonprofit healthcare
More informationMolina Healthcare of Ohio, Inc. PO Box 22712 Long Beach, CA 90801
Section 9. Claims As a contracted provider, it is important to understand how the claims process works to avoid delays in processing your claims. The following items are covered in this section for your
More informationTen Things Your Clients Wish You Knew About Medicare A CLE presentation for the CBA Elder Law Section
1 Ten Things Your Clients Wish You Knew About Medicare A CLE presentation for the CBA Elder Law Section Alice Ierley, Esq. Brown & Ierley, LLC alice@brownandierley.com 303-835-7001 Higher income clients:
More informationSome individuals are dual eligible meaning they qualify for both Medicaid and Medicare. In
Understanding Dual Eligibility The Interplay between Medicare and Medicaid Jason D. Lazarus, Esq. Introduction Some individuals are dual eligible meaning they qualify for both Medicaid and Medicare. In
More informationTable of Contents. State Plan Amendment (SPA) #: 09-021B This file contains the following documents in the order listed:
Table of Contents (Cover Page) for one PDF to post on Medicaid.gov Sample Template is below this line. Do not print the wording above this line. Table of Contents State/Territory Name: California State
More informationQuestions On Charges For The Uninsured. Q1: Can a hospital waive collection of charges to an indigent, uninsured individual?
2/17/04 2:11 pm Questions On Charges For The Uninsured Q1: Can a hospital waive collection of charges to an indigent, uninsured individual? A1: Yes. Nothing in the Centers for Medicare & Medicaid Services
More informationClosing the Coverage Gap
MEDICARE PRESCRIPTION DRUG COVERAGE REVISED MAY 2013 Information Pharmacists Can Use on: Closing the Coverage Gap The Affordable Care Act includes provisions to close the Medicare Part D prescription drug
More informationissue brief Medicaid: A Key Source of Insurance in New Hampshire
issue brief April 20, 2011 Medicaid: A Key Source of Insurance in New Hampshire As state and federal policymakers come to grips with substantial budget shortfalls both now and into the future one public
More informationHOUSE OF REPRESENTATIVES
HOUSE OF REPRESENTATIVES HB 2010 2013-2014; health; welfare; budget reconciliation. Sponsor: Representative Pratt DPA X Caucus and COW House Engrossed OVERVIEW HB 2010 includes provisions to health and
More informationExpanding 340B Participation: The Provider-Based Challenge
Expanding 340B Participation: The Provider-Based Challenge Presentation by Karen Smith, Esq. & David Johnston, Esq. Bricker & Eckler LLP www.bricker.com Columbus l Cleveland l Cincinnati-Dayton I Marietta
More informationGAO DRUG PRICING. Manufacturer Discounts in the 340B Program Offer Benefits, but Federal Oversight Needs Improvement
GAO United States Government Accountability Office Report to Congressional Committees September 2011 DRUG PRICING Manufacturer Discounts in the 340B Program Offer Benefits, but Federal Oversight Needs
More informationCenter for Medicaid and CHIP Services Disabled and Elderly Health Programs Group. January 30, 2014
DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services 7500 Security Boulevard, Mail Stop S2-14-26 Baltimore, Maryland 21244-1850 Center for Medicaid and CHIP Services Disabled
More informationOctober 27, 2015. Krista Pedley, Director Office of Pharmacy Affairs Health Resources and Services Administration.
1015 15 th Street, N.W., Suite 950 Washington, DC 20005 Tel. 202.204.7508 Fax 202.204.7517 www.communityplans.net John Lovelace, Chairman Margaret A. Murray, Chief Executive Officer October 27, 2015 Krista
More informationRE: 340B Drug Pricing Program Omnibus Guidance HRSA RIN 0906-AB08, (Vol. 80, No. 167, August 28, 2015)
October 26, 2015 Krista Pedley, PharmD, MS Captain, USPHS Director, Office of Pharmacy Affairs Health Resources and Services Administration 5600 Fishers Lane, Mail Stop 08W05A Rockville, MD 20857 Via Email:
More informationThe 340B Drug Discount Program
The 340B Drug Discount Program Ponaman Healthcare Consulting Ralph V. Moreno Jr. Presented: August 11, 2011 Table of Contents...1 THE 340B DRUG DISCOUNT PROGRAM 1.1 340B Overview......2 1.2 340B Eligibility.......
More informationMedicare Coverage Gap Discount Program (Filling the Donut Hole)
Medicare Coverage Gap Discount Program (Filling the Donut Hole) Summary: Requires drug manufacturers to provide a 50 percent discount to Part D beneficiaries for brand name drugs and biologics purchased
More informationOctober 27, 2015. Attention: RIN 0906-AB08. RE: 340B Drug Pricing Program Omnibus Guidance. Dear Captain Pedley:
Captain Krista Pedley, Director Office of Pharmacy Affairs Health Resources and Services Administration 5600 Fishers Lane Mail Stop 08W05A Rockville, MD 20857 Attention: RIN 0906-AB08 RE: 340B Drug Pricing
More informationJuly 27, 2015. Dear Acting Administrator Slavitt:
Acting Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-2390-P P.O. Box 8106 Baltimore, MD 21244-8016 Re: Proposed Rule for Medicaid and Children
More information